Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The collaboration, called BROADEN, focuses on continuous flow chemistry.
May 4, 2023
By: Tim Wright
Almac Sciences, a member of the Almac Group, has strengthened its collaboration with University College Dublin (UCD) that will focus on the development of novel continuous flow protocols for accessing new industrially relevant drug targets. The new project, entitled “BROADEN,” involves continuous flow in-situ Bromination for Application in the synthesis of Drugs and thEir buildiNg blocks. These are among the most fundamental transformations in organic chemistry, allowing the functionalization of simple substrate molecules to become advanced building blocks for today’s drugs. According to the company, successful completion of BROADEN will result in a competitive edge for chemical manufacturing in Ireland including societal impacts through improved access to cheaper chemicals and medicines, economic impacts (lowering cost of goods, shorter processes, less waste) and improved sustainability metrics. This is a four-year project, co-funded by Almac Sciences and the Irish Research Council, through their enterprise partnership scheme. It will develop methods that generate bromine from benign precursors and through continuous flow approaches, immediately consume the reactive intermediate in a variety of industrially relevant chemical transformations. The project expands the existing collaboration with Dr. Marcus Baumann at UCD where a range of projects utilizing continuous flow for both oxidations and enzyme mediated transformations are ongoing. Davin Cronly, PhD student at UCD, said, “This research is exciting as there is the potential to develop innovative solutions to complex scientific challenges. I want to use my knowledge as a chemist to make a real impact on the lives of those around me and I am looking forward to spending time at Almac Sciences to learn from industrial experts.” Dr. Megan Smyth, team leader and UKRI Future Leaders Fellow, Almac Sciences, said, “We are delighted to welcome Davin to the collaborative team we have established between Almac Sciences and UCD. I look forward to mentoring and working closely with Davin in the development of novel continuous flow protocols, applying/disseminating these outputs into industrial best-practice and wish him every success in his studies.”
Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !